Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-06-001489
Filing Date
2006-03-01
Accepted
2006-03-01 14:01:53
Documents
1
Period of Report
2006-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 3720
  Complete submission text file 0001005477-06-001489.txt   5525
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5 BILLERICA PARK 101 BILLERICA AVE NORTH BILLERCA MA 01862
Business Address
MUEHL DANIEL W (Reporting) CIK: 0001283569 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 06654388